| Literature DB >> 24944745 |
Derun Li1, Zhicai Wu1, Yang Yu1, Richard G Ball1, Liangqin Guo1, Edward Sherer1, Shuwen He1, Qingmei Hong1, Zhong Lai1, Hongbo Qi1, Quang Truong1, David X Yang1, Gary G Chicchi1, Kwei-Lan Tsao1, Dorina Trusca1, Maria Trujillo1, Michele Pachanski1, George J Eiermann1, Andrew D Howard1, Yun-Ping Zhou1, Bei B Zhang1, Ravi P Nargund1, William K Hagmann1.
Abstract
A novel class of small-molecule, highly potent, and subtype-selective somatostatin SST3 agonists was discovered through modification of a SST3 antagonist. As an example, (1R,2S)-9 demonstrated not only potent in vitro SST3 agonist activity but also in vivo SST3 agonist activity in a mouse oral glucose tolerance test (OGTT). These agonists may be useful reagents for studying the physiological roles of the SST3 receptor and may potentially be useful as therapeutic agents.Entities:
Keywords: GPCR; Somatostatin; small-molecule SST3 agonists; somatostin receptor subtype 3 (SST3)
Year: 2014 PMID: 24944745 PMCID: PMC4060944 DOI: 10.1021/ml500079u
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345